You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IFN-alpha2a

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatitis B, Chronic Trial in Hefei (PEGylated recombinant human interferon alpha-2b injection)

Recruiting
  • Hepatitis B, Chronic
  • PEGylated recombinant human interferon alpha-2b injection
  • Hefei, Anhui, China
    The First Affiliated Hospital of Anhui Medical University
Jun 24, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma, Unresectable Triple-Negative Breast

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Biopsy
  • +7 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 23, 2023

Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in

Recruiting
  • Hematopoietic and Lymphoid Cell Neoplasm
  • +2 more
  • Best Practice
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Mar 1, 2022

HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1

Recruiting
  • HLA-A2 Positive Cells Present
  • Refractory Melanoma
  • Alpha-type-1 Polarized Dendritic Cells
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 12, 2022

Hepatitis B, Chronic Trial in Shanghai (hepalatide, Pegylated Interferon, TAF)

Not yet recruiting
  • Hepatitis B, Chronic
  • Shanghai, Shanghai, China
    Shanghai Tong Ren Hospital
Nov 12, 2021

Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)

Active, not recruiting
  • Hepatitis B, Chronic
  • Hong Kong, Hong Kong
  • +5 more
Sep 27, 2021

Metastatic Carcinoma in the Liver, Recurrent Colorectal Carcinoma, Stage IV Colorectal Cancer AJCC v7 Trial in Buffalo (drug,

Completed
Has Results
  • Metastatic Carcinoma in the Liver
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Feb 25, 2022

Triple -Negative Breast Cancer, Estrogen Receptor Negative, HER2/Neu Negative Trial in Buffalo (procedure, drug, biological)

Active, not recruiting
  • Triple -Negative Breast Cancer
  • +4 more
  • Biopsy
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Aug 1, 2022

Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8, Stage IIIB Hepatocellular Carcinoma

Recruiting
  • Stage III Hepatocellular Carcinoma AJCC v8
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 18, 2021

Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8 Trial in

Suspended
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +18 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 4, 2022

Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors Trial in Pittsburgh (Chemokin Modulatory Regimen (5 MU/m2), Chemokin

Terminated
Has Results
  • Colorectal Cancer
  • +3 more
  • Chemokin Modulatory Regimen (5 MU/m2)
  • +2 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 21, 2020

Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

Not yet recruiting
  • Chronic Hepatitis B
  • PEG IFN α-2b; TAF
  • (no location specified)
Aug 5, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Scottsdale (Laboratory Biomarker Analysis, Quality-of-Life Assessment,

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Laboratory Biomarker Analysis
  • +2 more
  • Scottsdale, Arizona
    Mayo Clinic in Arizona
Jan 7, 2022

Malignant Tumor of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial

Completed
Has Results
  • Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface
  • +2 more
  • DC vaccine
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 6, 2020

Sarcoma, Kaposi, HIV Trial in Miami (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • Miami, Florida
    Univ of Miami School of Medicine
Oct 27, 2021

Malignant Pleural Mesothelioma Trial in Worldwide (rAd-IFN, Celecoxib Oral Product, Gemcitabine)

Active, not recruiting
  • Malignant Pleural Mesothelioma
  • rAd-IFN
  • +2 more
  • Los Angeles, California
  • +41 more
Oct 25, 2021

Leukemia Trial in Philadelphia (Interferon alpha-2B (IFN-a) 3 million units (MU) subcutaneous daily)

Completed
  • Leukemia
  • Interferon alpha-2B (IFN-α) 3 million units (MU) subcutaneous daily
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Apr 20, 2020

Sarcoma, Kaposi, HIV Trial in New York (Interferon alfa-2a, Zidovudine, Interferon alfa-n1)

Completed
  • Sarcoma, Kaposi
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • New York, New York
    Mem Sloan - Kettering Cancer Ctr
Oct 28, 2021

HIV, HIV/AIDS, HIV-1 Infection Trial in Philadelphia (Pegylated Interferon alpha 2b (peg-IFN-a2b), 3BNC117 + 10-1074)

Unknown status
  • HIV
  • +2 more
  • Pegylated Interferon alpha 2b (peg-IFN-α2b)
  • 3BNC117 + 10-1074
  • Philadelphia, Pennsylvania
  • +1 more
Jun 22, 2021

Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma, Advanced Squamous Cell Carcinoma Trial in Miami (Cemiplimab-Rwlc,

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +2 more
  • Miami, Florida
    Miami Cancer Institute at Baptist Health, Inc.
Feb 6, 2023

Hepatitis C Trial in Rotterdam (Peginterferon alfa-2a, Interferon alfa-2a, Ribavirin)

Completed
  • Hepatitis C
  • Peginterferon alfa-2a
  • +2 more
  • Rotterdam, Netherlands
    Erasmus Medical Center
Aug 26, 2021

HIV Trial in United States (Interferon alfa-2a, Zidovudine, Zalcitabine)

Completed
  • HIV Infections
  • Interferon alfa-2a
  • +2 more
  • Birmingham, Alabama
  • +3 more
Oct 27, 2021

Hepatitis B Trial in New Delhi (Peg IFN 2b)

Unknown status
  • Hepatitis B
  • Peg IFN 2b
  • New Delhi, Delhi, India
    Institute of Liver and Biliary Sciences
Feb 1, 2020

Peripheral Diabetic Neuropathy Trial in Peshawar (Resveratrol, Alpha lipoic acid, Super oxide dismutase, Resveratrol, Alpha

Active, not recruiting
  • Peripheral Diabetic Neuropathy
  • Resveratrol, Alpha lipoic acid, Super oxide dismutase
  • +3 more
  • Peshawar, KPK, Pakistan
    Syed Hamid Habib
Nov 12, 2023

Adult T-cell Leukemia-Lymphoma, ATLL Trial in Miami (Belinostat, Zidovudine, Interferon-Alfa-2b)

Recruiting
  • Adult T-cell Leukemia-Lymphoma
  • ATLL
  • Miami, Florida
    University of Miami
Jan 24, 2022